Advertisement

Topics

CELLnTEC Advanced Cell Systems Company Profile

21:47 EST 17th November 2017 | BioPortfolio

CELLnTEC's expertise with the development of epithelial progenitor cell culture systems is also available thorugh a selection of unique services.

Location

Laenggassstr 122
Postfach
Bern
CH-3001
Switzerland

Contact

Phone: 41 (0)31 631 2508
Fax: 41 (0)31 631 2635
Email: info@cellntec.com


News Articles [2176 Associated News Articles listed on BioPortfolio]

Advanced Cell Technology:Gary Rabin. Applying Stem Cell-Based Technologies to Create Patient-Specific Therapies

In this episode of PharmaTelevision News Review, filmed at BioEurope Spring 2013, in Barcelona, Spain, Fintan Walton talks to Gary Rabin, CEO of Advanced Cell Technology

More precise diagnostics for improved cancer outcomes

(University of Texas at Austin, Texas Advanced Computing Center) In the future, it may be possible to diagnose cancer much earlier using improved detection systems. Computing resources at the Texas Ad...

New book on Cell-Cell Junctions published by CSHLPress

(Cold Spring Harbor Laboratory Press) "Cell-Cell Junctions, Second Edition", published by Cold Spring Harbor Laboratory Press, reviews our understanding of the organization, regulation, and dynamics o...

Immunotherapy Safely Treats Advanced Squamous Cell Carcinoma

An anti–PD-1 monoclonal antibody is safe and effective for patients with unresectable, locally advanced, or metastatic cutaneous squamous cell carcinoma.

Opdivo in Combination with Yervo Demonstrates Improved Overall Survival for Advanced Renal Cell Carcinoma

A Phase 3 study evaluating Opdivo (nivolumab) plus Yervoy (ipilimumab) in patients with previously untreated advanced or metastatic renal cell […] The post Opdivo in Combination with Yervo Demon...

Bio-Techne enters Genomics market with $250M acquisition of Advanced Cell Diagnostics

Bio-Techne Corporation have agreed to acquire California-based molecular pathology company Advanced Cell Diagnostics for $250 million in cash plus additional potential milestone payments of up to $75M...

Advanced Cell Diagnostics raises $22 million USD in latest round of financing

Advanced Cell Diagnostics (ACD) have raised a further $22 million in Series C equity financing, with proceeds to be used to accelerate their entry into the research and clinical diagnostics

HemoGenix Licenses Assays and Reagents to Preferred Cell Systems

Colorado Springs, CO – HemoGenix, Inc. is pleased to announce that it has licensed the manufacturing, sales and marketing of its proprietary reagents and in vitro assay kits to Preferred Cell Sy...

PubMed Articles [5562 Associated PubMed Articles listed on BioPortfolio]

Guidelines for Developing Successful Short Advanced Courses in Systems Medicine and Systems Biology.

Systems medicine and systems biology have inherent educational challenges. These have largely been addressed either by providing new masters programs or by redesigning undergraduate programs. In contr...

Multicellular Biohybrid Materials: Probing the Interplay of Cells of Different Types Precisely Positioned and Constrained on 3D Wireframe-Like Microstructures.

Driven by the unbroken miniaturization trend in microtechnology, the development of smaller, yet reliable and efficient, highly integrated microsystems can benefit from inherent capabilities of biolog...

Principles of Systems Biology, No. 15.

This month: seeing systems through evolution's lens (Thomas/Prakash/Landry), single-cell analysis across space and time (Izkovitz/Melosh), simplicity revealed in E. coli metabolism (Sauer), and under...

Systematic Metrics Depicting Cell Death Kinetics.

In a recent issue of Cell Systems, Forcina et al. (2017) developed a scalable time-lapse analysis of cell death kinetics (STACK) method and combined it with a "lag exponential death" model to quantit...

Principles of Systems Biology, No. 16.

This month: how T cells signal in binary (Vale), advances in interaction mapping (Greenleaf/Sabatini/Ahroni/Bodenmiller), single-cell RNA-seq (Suvà/Ramanathan/Marioni), and more (Hilvert/Wong/Chisho...

Clinical Trials [10011 Associated Clinical Trials listed on BioPortfolio]

Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025)

The purpose of the study is to compare the clinical benefit, as measured by duration of overall survival, of Nivolumab vs. Everolimus in subjects with advanced or metastatic clear-cell ren...

A Phase 1 Study of the Clinical and Immunologic Effects of ALT-803 in Patients With Advanced Solid Tumors

The proposed clinical trial is a phase I, open-label, multi-center, dose-escalation study of ALT-803 in patients with surgically incurable advanced solid tumors: melanoma, renal cell, non-...

Clinical Outcome Of Advanced Renal Cell Carcinoma In Taiwan

The clinical outcome of advanced / metastatic renal cell carcinoma has been changed since targeted therapy being widely applied. This study will retrospectively analyse the clinical outcom...

Postpartum Immediate Contraception in Cesarean Deliveries-Comparison of Two Intrauterine Systems

To compare two intrauterine systems in order to avoid complications originating from short pregnancy interval and undesired pregnancies in the early postpartum period.

A Phase II Study to Treat Subjects With Advanced Renal Cell Carcinoma

The purpose of this study is to evaluate the effectiveness and safety of AMG 102 in patients with Advanced Renal Cancer.

Companies [3124 Associated Companies listed on BioPortfolio]

CELLnTEC Advanced Cell Systems

CELLnTEC's expertise with the development of epithelial progenitor cell culture systems is also available thorugh a selection of unique services.

One Cell Systems, Inc.

One Cell Systems is developing and marketing a family of single cell assays that rely on microencapsulation and flow cytometry. Technology underlying these products has been developed internally and l...

Biological Industries USA

Biological Industries (www.bioind.com) is one of the world’s leading and trusted suppliers to the life sciences industry, with over 35 years’ experience in cell culture ...

ADVANCED CELL & GENE THERAPY, LLC

ADVANCED CELL & GENE THERAPY, LLC, is a consulting firm serving biotechnology companies, clinical laboratories, and biotechnology investors. We provide practical, experienced guidance in development, ...

Advanced Cell Technology, Inc.

Advanced Cell Technology, Inc. is a biotechnology company applying cellular technology in the field of regenerative medicine. For more information, visit http://www.advancedcell.c...

More Information about "CELLnTEC Advanced Cell Systems" on BioPortfolio

We have published hundreds of CELLnTEC Advanced Cell Systems news stories on BioPortfolio along with dozens of CELLnTEC Advanced Cell Systems Clinical Trials and PubMed Articles about CELLnTEC Advanced Cell Systems for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CELLnTEC Advanced Cell Systems Companies in our database. You can also find out about relevant CELLnTEC Advanced Cell Systems Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record